Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates. It specializes in improving the solubility and bioavailability of poorly water-soluble drugs using its suite of nanotechnology platforms. Ascendia formulates products for injectable, oral, and topical routes ofadministration. The company has three technology platforms - EmulSol for producing nano-emulsions, AmorSol for creating amorphous solid dispersions, and NanoSol for formulating nano-particles.

Biotechnology

Health Care

Pharmaceutical

Ascendia

Jim Jingjun Huang

Jose Parra

Christopher Todd

Kathy Avalos

Junling Wang

M Asif

Robert Bloder

Ariana Cerminaro

Shaukat Ali

The Scientific and Engineering Team at Ascendia Pharmaceuticals specializes in the development and optimization of drug formulations to enhance the solubility and bioavailability of poorly water-soluble drugs. Leveraging Ascendia's proprietary nanotechnology platforms (EmulSol, AmorSol, and NanoSol), the team conducts pre-formulation studies and creates innovative products for injectable, oral, and topical administration. Their work is crucial in advancing drug candidates from preclinical to clinical stages, ensuring efficacy and safety.

Scientific and Engineering Team

Leadership Team

Scientific and Engineering Team

About

Team members

Other teams at Ascendia

Leadership Team